Grand Blanc-based McLaren Health Care Names Dr. Justin Klamerus as Chief Medical Officer

61
Courtesy of McLaren Health Care
Courtesy of McLaren Health Care

McLaren Health Care, 14-hospital health care system and health plan, has appointed Dr. Justin F. Klamerus as executive vice president and chief medical officer (CMO) at the Grand Blanc location.

He assumed the position previously held by Dr. Michael McKenna, McLaren Health Care’s first CMO, who passed away in May.

“Over what has already been an exceptional career, Dr. Klamerus has proven himself to be a compassionate physician and a capable and confident leader, one who has already developed a rapport with many of our physician leaders around the system,” says Phil Incarnati, president and CEO of McLaren Health Care.

“Dr. McKenna’s accomplishments at McLaren reached far, and he leaves a well-earned legacy. His loss was very tough on all of us, but it’s pleasing to know that one of his most trusted mentees will succeed him and build on his significant contributions to our clinical quality improvements. Dr. Klamerus will be a welcomed addition to our leadership team.”

In his role, Klamerus will recommend, develop, and supervise the implementation of medical care aimed toward improving patients’ clinical outcomes while establishing a single standard of care across the McLaren system.

His immediate objectives include continuing to build on McLaren’s established success of service excellence, clinical quality, and health equity, solidifying the system as the health care provider of choice in the communities it serves.

Following his graduation from Olivet College, Dr. Klamerus earned his medical degree from the Michigan State University College of Human Medicine. He completed his internal medicine residency, achieving the position of chief resident at Ohio State University before continuing his education with a medical oncology fellowship at Johns Hopkins University.

In 2009 as a practicing oncologist, Dr. Klamerus served as the program director of Cancer Services at McLaren Northern Michigan in Petoskey before becoming president of the McLaren Cancer Institute.

In 2014, when McLaren acquired the Karmanos Cancer Institute, he assumed the role of executive vice president and chief quality officer at Karmanos before being named the organization’s president.

Facebook Comments